TOP NEWS

Persistent Systems’ Q2 Net Profit Rises 23%, Revenue Grows 20%

Sun Pharma Q2 Results

October 23, 2024

New Delhi, India

Q2 Results

Persistent Systems Ltd reported strong financial results for the second quarter ending September 30, 2024. The mid-tier IT company posted a 23.4% year-on-year (YoY) increase in net profit, reaching ₹325 crore, compared to ₹263 crore in the same period last year. Revenue from operations surged by 20.1%, totaling ₹2,897 crore against ₹2,412 crore in the year-ago quarter.

Key Financial Highlights

  • Net Profit: ₹325 crore (up 23.4% YoY)
  • Revenue: ₹2,897 crore (up 20.1% YoY)
  • EBIT: ₹406.2 crore (up 5.8% QoQ)
  • EBIT Margin: Flat at 14% compared to the previous quarter
  • Dollar Revenue: $345.5 million (up 5.3% QoQ)
  • Constant Currency Growth: 5.1% QoQ

Also Read: Godavari Biorefineries IPO Opens for Subscription at ₹334-352 Per Share

Order Book and Future Outlook

Persistent Systems’ order booking for Q2 stood at $529 million in total contract value (TCV) and $348.3 million in annual contract value (ACV). CEO Sandeep Kalra expressed pride in the company’s 18th consecutive quarter of revenue growth, emphasizing advancements in AI-led, platform-driven services and expansions in digital governance.

Also Read: IMF Maintains India’s Growth Forecast at 7% for FY25, 6.5% for FY26

Latest Q2 Results

Currency Market Live Updates

Disclaimer:

CurrencyVeda provides this news article for informational purposes only. We do not offer investment advice or recommendations. Before making any investment decisions, please conduct thorough research, consult with financial experts, and carefully consider your financial situation, risk tolerance, and investment goals. Investing in the stock market carries risks, and it’s essential to make informed choices based on your individual circumstances. CurrencyVeda is not liable for any actions taken based on the information provided in this article.